Divestment9 Jul 2026, 04:41 pm
Hester Biosciences Sells 11% Stake in Texas Lifesciences for ₹23 Million
AI Summary
Hester Biosciences Ltd has divested its entire remaining 11% equity stake in Texas Lifesciences Private Limited (TLPL), comprising 543,248 equity shares. The sale was executed on July 8, 2026, to existing shareholders of TLPL for an aggregate consideration of INR 23 million. Following this transaction, Hester Biosciences no longer holds any equity investment in TLPL, marking a complete exit from its shareholding in the subsidiary. This disclosure is made in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Key Highlights
- Hester Biosciences exits its investment in Texas Lifesciences.
- Sale of remaining 11% stake completed for ₹23 million.
- Company's shareholding in TLPL reduced from 11% to Nil.
- Transaction aligns with Board of Directors' approved terms.
Price Impact
More from HESTERBIO